Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Neoplasms 1 Lupus Erythematosus, Systemic 1 Infections 1

Interventions

Specimen Handling 186 pembrolizumab 151 Magnetic Resonance Spectroscopy 151 Carboplatin 114 Biopsy 104 Cyclophosphamide 96 Cisplatin 88 Paclitaxel 79 Gemcitabine 71 Bevacizumab 68 fludarabine 60 Nivolumab 58 Fluorouracil 51 Radiotherapy 49 Dexamethasone 47 Capecitabine 47 Pemetrexed 46 Oxaliplatin 44 Docetaxel 44 Rituximab 43 Leucovorin 41 Doxorubicin 40 venetoclax 39 durvalumab 39 atezolizumab 39 Temozolomide 32 Standard of Care 32 Radiation 32 Cetuximab 32 130-nm albumin-bound paclitaxel 32

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × anifrolumab × 30 days × Clear all

NCT07000110 2026-05-20

SIMA

AstraZeneca

Infections, Lupus Erythematosus, Systemic, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡